These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Complications of Stevens-Johnson syndrome beyond the eye and skin. Saeed H; Mantagos IS; Chodosh J Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527 [TBL] [Abstract][Full Text] [Related]
3. Stevens Johnson Syndrome: Past, Present, and Future Directions Gynecologic Manifestations and Management in SJS/TEN. DenAdel MA; Hendrickson SE; Fuchs E Front Med (Lausanne); 2022; 9():874445. PubMed ID: 35860738 [TBL] [Abstract][Full Text] [Related]
4. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. Lee HY; Walsh SA; Creamer D Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971 [TBL] [Abstract][Full Text] [Related]
5. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Schneider JA; Cohen PR Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852 [TBL] [Abstract][Full Text] [Related]
7. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience. Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications. Ueta M Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401 [TBL] [Abstract][Full Text] [Related]
10. Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in Brazil. Wakamatsu TH; Dos Santos MS; Barreiro TP; Sant'Anna AEBPP; Murta F; da Costa AX; Marculino LGC; de Alcântara RJA; de Farias CC; Gomes JÁP Front Med (Lausanne); 2021; 8():649369. PubMed ID: 34222274 [TBL] [Abstract][Full Text] [Related]
11. Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in India. Shanbhag SS; Sangwan VS; Singh A; Donthineni PR; Basu S; Srinivasan B; Agarwal S; Iyer G Front Med (Lausanne); 2021; 8():643955. PubMed ID: 34513854 [TBL] [Abstract][Full Text] [Related]
12. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094 [TBL] [Abstract][Full Text] [Related]
13. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J Ocul Surf; 2016 Apr; 14(2):168-88. PubMed ID: 26882981 [TBL] [Abstract][Full Text] [Related]
14. Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). Clayton NA; Kennedy PJ Dysphagia; 2007 Jul; 22(3):187-92. PubMed ID: 17287925 [TBL] [Abstract][Full Text] [Related]
15. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131 [TBL] [Abstract][Full Text] [Related]
16. Ophthalmic Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review. Tóth G; Lukács A; Schirra F; Sándor GL; Killik P; Maneschg OA; Nagy ZZ; Szentmáry N Ophthalmol Ther; 2023 Aug; 12(4):1795-1811. PubMed ID: 37140876 [TBL] [Abstract][Full Text] [Related]
17. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital. Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525 [TBL] [Abstract][Full Text] [Related]